Home
>
Active Pharmaceutical Ingredients
>
Other Chemical Drugs
>
Daclatasvir dihydrochloride
for Sale
>
Daclatasvir dihydrochloride
Daclatasvir dihydrochloride
Unit Price:
Get Latest Price
CAS No.:
1009119-65-6
Port:
Shanghai Port
Packaging:
1kg;10kg
Price valid (until):
2023-08-05
Company Type:
Trader
Location:
China
Qualification:
Main Products:
Upadacitinib Hemihydrate,(S)-(+)-1-Boc-3-hydroxypyrrolidine
-
Product Description
-
Seller Information
-
DescriptionBasic Info
-
Product Name:
Daclatasvir dihydrochloride
Other Name:Carbamic acid,N,N′-[[1,1′-biphenyl]-4,4′-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-,C,C′-dimethyl ester,hydrochloride (1:2);Daclatasvir dihydrochloride;BMS 790052-05;Daklinza
CAS No.:1009119-65-6
Molecular Formula:C40H50N8O6.2ClH
InChIKeys:InChIKey=BVZLLUDATICXCI-JMSCDMLISA-N
Molecular Weight:811.8
Exact Mass:810.3386868
UNII:50ZO25C11D
NCI Thesaurus Code:C166798
ATC Code:J05AP07
Categories:
Characteristics -
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Upadacitinib Hemihydrate,(S)-(+)-1-Boc-3-hydroxypyrrolidine
-
Location:
Honggutan District, Nanchang City, Jiangxi Province
-
Payment Terms:
TT against copy of documents,L/C
-
Average lead Time:
50
-
Total Annual Revenue:
$2.5 million-$5 million
-
Total Employees:
11-50
-
Year of Establishment:
2021
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product